SCHEMBL1071007

SCHEMBL1071007

CCOC(=O)CC(O)(CC(=O)OC(C)=O)C(=O)OCC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PKM P14618 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 2/20 0.39
MGAM O43451 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
SOAT1 P35610 1/20 0.39
THRB P10828 1/20 0.39
HTT P42858 1/20 0.38
TRPA1 O75762 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPT P10636 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HSD11B1 P28845 1/20 0.33
RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5676728 0.90 ALDH1A1 (0.38) ALDH1A1LMNAHSD17B10PKMKDM4E
Triethyl Citrate SCHEMBL28306859 0.89 ALDH1A1 (0.43) ALDH1A1LMNAHSD17B10PKMKDM4E
SCHEMBL1071009 0.89 ALDH1A1 (0.43) ALDH1A1LMNAHSD17B10PKMKDM4E
Triethyl Citrate SCHEMBL23465 0.89 GAA (0.48) ALDH1A1LMNAHSD17B10PKMKDM4E
Triethyl Citrate SCHEMBL901127 0.89 GAA (0.48) ALDH1A1LMNAHSD17B10PKMKDM4E
Triethyl Citrate SCHEMBL5162146 0.87 PKM (0.43) ALDH1A1LMNAHSD17B10PKMKDM4E
Triethyl Citrate SCHEMBL29035980 0.87 GAA (0.46) ALDH1A1LMNAHSD17B10PKMKDM4E
Triethyl Citrate SCHEMBL28041956 0.87 GAA (0.46) ALDH1A1LMNAHSD17B10PKMKDM4E
Triethyl Citrate SCHEMBL6236671 0.87 GAA (0.46) ALDH1A1LMNAHSD17B10PKMKDM4E
Triethyl Citrate SCHEMBL14856311 0.87 GAA (0.46) ALDH1A1LMNAHSD17B10PKMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114306284-B Monnpiravir taste masking granule and preparation method thereof 南京正济医药研究有限公司 2023-11-03 CN claimed
CN-114306284-A Molnopiravir taste masking granules and preparation method thereof 南京正济医药研究有限公司 2022-04-12 CN claimed
CN-111298667-B Polymer-based blended film, and preparation method and application thereof 中国科学院大连化学物理研究所 2021-12-07 CN claimed
CN-113262208-A Azithromycin taste-masking dry suspension granule and preparation method thereof 北京科信必成医药科技发展有限公司 2021-08-17 CN claimed
CN-111298667-A Polymer-based blended film, and preparation method and application thereof 中国科学院大连化学物理研究所 2020-06-19 CN claimed
CN-105982860-B Guaifenesin water-free swallowable taste-masking granule 北京科信必成医药科技发展有限公司 2020-04-14 CN claimed
WO-2015150293-A1 NAIL CARE COMPOSITION ZHUWU ZEYI (DE) 2015-10-08 WO claimed
EP-4632013-A1 INORGANIC PARTICLE DISPERSED SLURRY COMPOSITION AND METHOD FOR PRODUCING INORGANIC SINTERED BODY Sekisui Chemical Co., Ltd. (JP) 2025-10-15 EP disclosed
CN-115772330-B Inorganic fine particle dispersion slurry composition and method for producing inorganic fine particle dispersion sheet using same 积水化学工业株式会社 2025-02-11 CN disclosed
CN-119384468-A Inorganic particle dispersion slurry composition and method for producing inorganic sintered body 积水化学工业株式会社 2025-01-28 CN disclosed
CN-115487761-B Modified esterification reaction kettle 江苏雷蒙新材料有限公司 2025-01-21 CN disclosed
WO-2024154467-A1 (METH)ACRYLIC RESIN PARTICLES, VEHICLE COMPOSITION, SLURRY COMPOSITION, AND METHOD FOR MANUFACTURING ELECTRONIC COMPONENT 積水化学工業株式会社 2024-07-25 WO disclosed
WO-2024122491-A1 INORGANIC PARTICLE DISPERSED SLURRY COMPOSITION AND METHOD FOR PRODUCING INORGANIC SINTERED BODY 積水化学工業株式会社 2024-06-13 WO disclosed
EP-3129547-A1 FIBERS WITH FILLER Georgia-Pacific Consumer Products LP (US) 2017-02-15 EP disclosed
WO-2015150293-A1 NAIL CARE COMPOSITION ZHUWU ZEYI (DE) 2015-10-08 WO disclosed
EP-2268793-A2 COMPOSITIONS METHODS AND KITS FOR ENHANCING IMMUNE RESPONSE TO A RESPIRATORY CONDITION The Procter & Gamble Company (US) 2011-01-05 EP disclosed
WO-2009100331-A2 COMPOSITIONS METHODS AND KITS FOR ENHANCING IMMUNE RESPONSE TO A RESPIRATORY CONDITION THE PROCTER & GAMBLE COMPANY (US) 2009-08-13 WO disclosed
EP-1969051-A2 INHIBITORS OF FATTY ACID AMIDE HYDROLASE N.V. Organon (NL) 2008-09-17 EP disclosed
WO-2007079180-A2 INHIBITORS OF FATTY ACID AMIDE HYDROLASE N.V. ORGANON (NL) 2007-07-12 WO disclosed
WO-1994010238-A1 METHOD FOR INCREASING THE BIODEGRADABILITY OF CELLULOSE ESTERS EASTMAN KODAK COMPANY (US) 1994-05-11 WO disclosed